For drug manufacturers striving to simplify raw material selection while satisfying regulatory requirements, our Emprove® Chemicals portfolio contains over 400 pharmaceutical raw materials organized by different levels of risk.
All raw and starting materials are organized into categories to streamline selection, with each product offering the comprehensive, up-to-date documentation you need to navigate regulatory challenges, manage risks, and improve processes.
Critical raw materials used during production processes have no clearly defined regulatory standards or quality requirements, but are coming more and more into regulatory focus. We continue to advance our Emprove® Chemicals portfolio with the recent addition of the Emprove® Evolve product line, providing fit-for-purpose high-quality raw materials for early stage manufacturing applications. As developing regulatory requirements for critical raw materials pose new challenges, we will continue to evolve our offerings to support your quality risk assessment with detailed documentation and supply chain transparency and control.
As part of the Emprove® Program, the complete Emprove® Evolve, Essential, and Expert chemicals portfolio is supported by Emprove® Dossiers. This comprehensive documentation facilitates your qualification, risk assessment, and process optimization efforts.
Emprove® API products come with the Emprove® API Information Package which supports API qualification and risk assessment. It includes:
We support our partners in their risk assessment efforts by providing detailed information about the applied Quality Management system, the supply chain, extractable data, and data on the stability of a product. To learn more, select any of the criteria below for our Quality & Service Catalog.
Unlock all the benefits of the Emprove® Chemicals portfolio by subscribing to our Emprove® Suite. Available exclusively for subscribers, all dossiers of the entire Emprove® portfolio can be accessed at your convenience.
To subscribe today, simply complete and submit the reply form below after reading our Emprove® terms and conditions.
Webinar: New PDA/IPEC Technical Report on excipient risk assessment – insights for drug product manufacturers
Webinar: BioPhorum Raw Materials Risk Assessments
Webinar: The Emprove® Program – an introduction focusing on the Emprove® Suite and Emprove® Chemicals content
Webinar: New developments of excipient regulations in China
Webinar: Nitrosamines - New Requirements to Evaluate Contamination Risks
White Paper: Identifying Appropriate-quality Raw Materials in an Evolving Regulatory Environment
Risk Mitigation Tool: Support for Biomanufacturing Processes